Open AccessIntravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
Author(s) -
Bernardete Pessoa,
Luísa Malheiro,
Inês Carneiro,
Sílvia Monteiro,
João Coelho,
Constança Coelho,
João Figueira,
Angelina Meireles,
João Melo Beirão
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s280644
Subject(s) - ranibizumab , medicine , aflibercept , bevacizumab , ophthalmology , diabetic macular edema , visual acuity , diabetic retinopathy , surgery , diabetes mellitus , chemotherapy , endocrinology
To evaluate the efcacy of switching from bevacizumab to ranibizumab or aflibercept in eyes with diabetic macular edema (DME) unresponsive to bevacizumab.